Pharmalot Pharmalot March 4, 2025 STAT Plus: To fight U.S. tariffs, Canada should suspend U.S. patents on medicines, one expert argues
Pharmalot Pharmalot March 4, 2025 STAT Plus: FDA scolds drugmaker over promotion that touts ‘misleading’ comparison with generics
Pharmalot Pharmalot March 4, 2025 STAT Plus: Pharmalittle: We’re reading about Pfizer navigating tariffs, Makary’s pledge to avoid conflicts, and more
Pharmalot Pharmalot March 3, 2025 STAT Plus: After Canada required pharma to pay fees, drug agency recommended coverage more often
Pharmalot Pharmalot March 3, 2025 STAT Plus: Pharmalittle: We’re reading about HHS reducing public comment, a Lilly obesity drug ad, and more